Cabaletta Bio (CABA) Net Equity Issued and Repurchased (2019 - 2025)

Cabaletta Bio's Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at -$25000.0 for Q3 2025.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$25000.0 in Q3 2025; TTM through Dec 2025 was $93.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $93.6 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased slipped to -$25000.0 in Q3 2025 per CABA's latest filing, from $93.6 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $93.8 million in Q2 2023 and bottomed at -$5.7 million in Q2 2024.
• The 5-year median for Net Equity Issued and Repurchased is $5.7 million (2024), against an average of $20.5 million.
• Across the five-year window, Net Equity Issued and Repurchased surged 1354400.0% in 2021 and plunged 106.12% in 2024, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $13.5 million in 2021, then surged by 142.6% to $32.9 million in 2022, then plunged by 105.24% to -$1.7 million in 2023, then slumped by 233.49% to -$5.7 million in 2024, then jumped by 99.56% to -$25000.0 in 2025.
• Per Business Quant, the three latest CABA Net Equity Issued and Repurchased figures stand at -$25000.0 (Q3 2025), $93.6 million (Q2 2025), and -$5.7 million (Q2 2024).